Page last updated: 2024-09-03

ly 293558 and Ache

ly 293558 has been researched along with Ache in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alt, A; Arnold, BM; Bell, MG; Bleakman, D; Bleisch, TJ; Buckmaster, JL; Castano, AM; Del Prado, M; Dominguez, E; Escribano, A; Filla, SA; Ho, KH; Hudziak, KJ; Iyengar, S; Jones, CK; Martinez-Perez, JA; Mateo, A; Mathes, BM; Mattiuz, EL; Ogden, AM; Ornstein, PL; Shannon, HE; Simmons, RM; Stack, DR; Stratford, RE; Winter, MA; Wu, Z1
Alt, A; Arnold, BM; Bell, MG; Bleakman, D; Bleisch, TJ; CastaƱo, AM; Clawson, DK; Del Prado, M; Dominguez, E; Escribano, AM; Filla, SA; Ho, KH; Hudziak, KJ; Iyengar, S; Jones, CK; Martinez-Perez, JA; Mateo, A; Mathes, BM; Mattiuz, EL; Ogden, AM; Ornstein, PL; Shannon, HE; Simmons, RM; Stack, DR; Stratford, RE; Winter, MA; Wu, Z1
Lam, V; Schettler, J; Wallace, MS1
Caruso, R; Chappell, AS; Gracely, RH; Hostetter, MP; Lee, G; Max, MB; Sang, CN; Schoepp, DD; Whitcup, S1
Gilron, I1

Reviews

1 review(s) available for ly 293558 and Ache

ArticleYear
LY-293558. Eli Lilly & Co.
    Current opinion in investigational drugs (London, England : 2000), 2001, Volume: 2, Issue:9

    Topics: Animals; Cerebrovascular Disorders; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Contraindications; Excitatory Amino Acid Antagonists; Humans; Isoquinolines; Pain; Receptors, AMPA; Structure-Activity Relationship; Tetrazoles

2001

Trials

2 trial(s) available for ly 293558 and Ache

ArticleYear
NGX426, an oral AMPA-kainate antagonist, is effective in human capsaicin-induced pain and hyperalgesia.
    Pain medicine (Malden, Mass.), 2012, Volume: 13, Issue:12

    Topics: Adult; Capsaicin; Cross-Over Studies; Double-Blind Method; Humans; Hyperalgesia; Isoquinolines; Male; Pain; Pain Measurement; Prodrugs; Receptors, AMPA; Receptors, Kainic Acid; Sensory System Agents; Tetrazoles; Young Adult

2012
AMPA/kainate antagonist LY293558 reduces capsaicin-evoked hyperalgesia but not pain in normal skin in humans.
    Anesthesiology, 1998, Volume: 89, Issue:5

    Topics: Adult; Analgesics, Non-Narcotic; Capsaicin; Dose-Response Relationship, Drug; Hot Temperature; Humans; Hyperalgesia; Isoquinolines; Male; Middle Aged; Nociceptors; Pain; Pain Measurement; Pain Threshold; Physical Stimulation; Receptors, AMPA; Receptors, Kainic Acid; Skin; Tetrazoles

1998

Other Studies

2 other study(ies) available for ly 293558 and Ache

ArticleYear
Two prodrugs of potent and selective GluR5 kainate receptor antagonists actives in three animal models of pain.
    Journal of medicinal chemistry, 2005, Jun-30, Volume: 48, Issue:13

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amino Acids; Analgesics; Animals; Biological Availability; Cell Line; Disease Models, Animal; Humans; Hyperalgesia; Pain; Rats; Receptors, AMPA; Receptors, Kainic Acid; Recombinant Proteins; Spinal Cord

2005
GluK1 antagonists from 6-(tetrazolyl)phenyl decahydroisoquinoline derivatives: in vitro profile and in vivo analgesic efficacy.
    Bioorganic & medicinal chemistry letters, 2013, Dec-01, Volume: 23, Issue:23

    Topics: Administration, Oral; Amino Acid Sequence; Animals; Disease Models, Animal; Isoquinolines; Male; Molecular Sequence Data; Pain; Prodrugs; Rats; Rats, Sprague-Dawley; Receptors, Kainic Acid; Structure-Activity Relationship; Tetrazoles

2013